Showing results (21-30 of 147) with videos related to
Sort By:
Pageof 15
Lung Cancer (Amsterdam, Netherlands)|September 15, 2004
A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lungMario Guerrieri, Kevin Wong, Gail Ryan, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 8, 2018
Programmed death ligand-1 expression in non-small cell lung cancer in a Western Australian population and correlation with clinicopathologic featuresLinda Ye, Connull Leslie, Angela Jacques, et al.Clinical Biochemistry|December 20, 2014
Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCRAnna L Reid, James B Freeman, Michael Millward, et al.Oncogene|December 23, 2022
ATX-101, a cell-penetrating protein targeting PCNA, can be safely administered as intravenous infusion in patients and shows clinical activity in a Phase 1 studyCharlotte Rose Lemech, Ganessan Kichenadasse, Jens-Peter Marschner, et al.Journal of Biosciences|February 24, 2012
Cytotoxic effects of the novel isoflavone, phenoxodiol, on prostate cancer cell linesSimon Mahoney, Frank Arfuso, Pierra Rogers, et al.European Journal of Medical Genetics|June 6, 2020
Impact of direct-to-consumer genetic testing on Australian clinical genetics servicesMichael Millward, Jane Tiller, Michael Bogwitz, et al.Pathology Oncology Research : POR|June 8, 2020
Detection of Low-level EGFR c.2369 C > T (p.Thr790Met) Resistance Mutation in Pre-treatment Non-small Cell Lung Carcinomas Harboring Activating EGFR Mutations and Correlation with Clinical OutcomesLinda Ye, Nima Mesbah Ardakani, Carla Thomas, et al.Pathology|May 13, 2018
Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practiceTindaro Giardina, Cleo Robinson, Fabienne Grieu-Iacopetta, et al.Cancer Investigation|November 13, 2025
Prognostic Value of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Lactate Dehydrogenase Level in Melanoma Patients Treated with Immune Checkpoint InhibitorsWynne Wijaya, Muhammad Adnan Khattak, Afaf Abed, et al.BMC Cancer|June 12, 2014
Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanomaDragana Klinac, Elin S Gray, James B Freeman, et al.Pageof 15